Posaconazole (MK-5592) Intravenous and Oral in Children (<2 Years) With Invasive Fungal Infection (MK-5592-127)
Clinical trial NCT04665037 · RECRUITING
Trial details
- NCT number
- NCT04665037
- Sponsor
- Merck Sharp & Dohme LLC
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-02-22
- Primary completion
- 2027-03-31
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.